BILLERICA, Mass. & SAN DIEGO--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL) and Gen-Probe (NASDAQ:GPRO) today announced the launch of the first product from their ground-breaking collaboration to create faster, sensitive, more robust tests for detecting contaminants in pharmaceutical and biotechnology manufacturing processes. The MilliPROBE system is the first solution of its kind for biopharmaceutical manufacturing. It combines Millipore’s leading, industry-accepted sample prep methodologies with Gen-Probe’s advanced, proven nucleic acid technologies to deliver both speed and sensitivity in one microbial screening tool.
